GUD — Knight Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual balance sheet for Knight Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	428	411	163	191	158
Net Total Accounts Receivable
Net Total Receivables	112	82	67.4	110	110
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	622	552	305	396	365
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29	26.2	29.9	22.6	17.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,305	1,040	992	1,055	945
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	351	114	105	141	114
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	495	153	150	229	199
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	811	886	842	826	747
Total Liabilities & Shareholders' Equity	1,305	1,040	992	1,055	945
Total Common Shares Outstanding